BFM
TFFP

Boothbay Fund Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Boothbay Fund Management’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-501
Closed -$72K – 1268
2020
Q2 		$72K Sell
501
-126
-20% -$15.9K ﹤0.01% 903
2020
Q1 		$60K Sell
627
-368
-37% -$43.8K 0.01% 774
2019
Q4 		$133K Buy
+995
New +$128K 0.01% 741

Other funds holding TFFP

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Precept Management Dallas, Texas $126M AUM 36.77% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Boothbay Fund Management's TFFP Position: Q3 2020 in Review

Boothbay Fund Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q3 2020, closing a stake of 501 shares — an estimated $72K sold.

Boothbay Fund Management first reported a position in TFFP in Q4 2019 and held it in 3 quarters. The position peaked at $133K in Q4 2019. 39 funds tracked by Wall St. Rank hold TFFP as of Q3 2020.

  • Boothbay Fund Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Boothbay Fund Management sold 501 TFF Pharmaceuticals, Inc. Common Stock shares in Q3 2020, an estimated $72K.
  • Boothbay Fund Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 3 quarters.
  • Boothbay Fund Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $133K in Q4 2019.
  • 39 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q3 2020.

Based on Boothbay Fund Management's 13F filing for Q3 2020, filed 16 Nov 2020.